Cannabis and Hemp Industry Investment News
The combination of two formulations, Mg Optima Relax and CBD, promote relaxation and reduces stress. The first order of 5,000 units has been manufactu...
The pharmaceutical tech group has developed several lines of skin cosmetic products InnoCan's contract manufacturer for the products Fancystage is in ...
The application is being made following the National Institute of Allergy and Infectious Diseases (NIAID) Funding Opportunity Announcement (FOA) RFA-A...
InnoCan is working to develop a treatment that would utilize CBD-loaded exosomes to treat coronavirus in the lungs Israel-based Innocan Pharma is a sp...
A share purchase plan is also underway with proceeds from both activities to smooth the path of the company’s NanaBis™ to Phase 3 trials submissions. ...
What are you searching for? viewEXMceuticals Inc (CSE: EXM) CEO Jonathan Summers joined Steve Darling from Proactive Vancouver to discuss the company ...
Econnabis SAS, a subsidiary of Plena Global Holdings Inc, will supply up to 200 kilograms of GMP-compliant THC distillate EXMceuticals is planning to ...
The company’s newest cannabinoid formulation treats patients with chemotherapy-induced nausea and vomiting (CINV). NanoCBD will undergo clinical trial...
Innocan’s largest shareholder Tamar Innovest purchased nearly 3.9 million units representing approximately 19.6% ownership of the company The financin...
What are you searching for? viewInnoCan Pharma Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive with news the company...
The Israel-based company said it plans to start shipping product internationally within two weeks nnoCan Pharma is a pharmaceutical tech company devel...
Novel drug delivery platform DehydraTECH masks unwanted tastes, improves onset speed, increases bioavailability of active ingredientsCannabis is the c...
TASALK is a world-leading fully integrated manufacturer and exporter of controlled substance extracts, including medicinal opiates and cannabis produc...
What are you searching for? viewCanntab Therapeutics Ltd Canntab Therapeutics (CSE: PILL- OTCQB: CTABF) CFO Richard Goldstein and Special Advisor Larr...
Canntab said it was kicking off production of its instant release tablets today and already received its first order under the deal with MediPharm The...
The company plans to use the proceeds for research and product development expenses, marketing expenses, and administrative expenses Innocan Pharma is...
The application stakes out a claim for a topical pharma composition to treat the symptoms of itching and inflammation associated with psoriasis The gl...
What are you searching for? viewInnoCan Pharma InnoCann Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver with news ...
Innocan believes that CBD-loaded exosomes may hold the potential to provide anti-inflammatory properties and help infected lung cells to recover Innoc...
Joshi Laxminarayan's expertise includes areas such as nano emulsion, extended release, and poorly soluble drug development Laxminarayan previously act...
